[1]
|
Furin, J., Cox, H. and Pai, M. (2019) Tuberculosis. The Lancet, 393, 1642-1656.
https://doi.org/10.1016/S0140-6736(19)30308-3
|
[2]
|
Hnizdo, E., Singh, T. and Churchyard, G. (2000) Chronic Pulmonary Function Impairment Caused by Initial and Recurrent Pulmonary Tuberculosis Following Treatment. Thorax, 55, 32-38. https://doi.org/10.1136/thorax.55.1.32
|
[3]
|
Amaral, A.F., Coton, S., Kato, B., et al. (2015) Tuberculosis Associates with Both Airflow Obstruction and Low Lung Function: BOLD Results. European Respiratory Journal, 46, 1104-1112.
https://doi.org/10.1183/13993003.02325-2014
|
[4]
|
Byrne, A.L., Marais, B.J., Mitnick, C.D., et al. (2015) Tuberculosis and Chronic Respiratory Disease: A Systematic Review. International Journal of Infectious Diseases, 32, 138-146. https://doi.org/10.1016/j.ijid.2014.12.016
|
[5]
|
Gläser, S., Krüger, S., Merkel, M., et al. (2015) Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Systematic Review of the Literature. Respiration, 89, 253-264. https://doi.org/10.1159/000369863
|
[6]
|
Brode, S.K., Daley, C.L. and Marras, T.K. (2014) The Epidemiologic Relationship between Tuberculosis and Non-Tuberculous Mycobacterial Disease: A Systematic Review. International Journal of Tuberculosis and Lung Disease, 18, 1370-1377. https://doi.org/10.5588/ijtld.14.0120
|
[7]
|
Jhun, B.W., Jung, W.J., Hwang, N.Y., et al. (2017) Risk Factors for the Development of Chronic Pulmonary Aspergillosis in Patients with Nontuberculous Mycobacterial Lung Disease. PLoS ONE, 12, e188716.
https://doi.org/10.1371/journal.pone.0188716
|
[8]
|
Naito, M., Kurahara, Y., Yoshida, S., et al. (2018) Prognosis of Chronic Pulmonary Aspergillosis in Patients with Pulmonary Non-Tuberculous Mycobacterial Disease. Respiratory Investigation, 56, 326-331.
https://doi.org/10.1016/j.resinv.2018.04.002
|
[9]
|
(1970) Aspergilloma and Residual Tuberculous Cavities—The Results of a Resurvey. Tubercle, 51, 227-245.
https://doi.org/10.1016/0041-3879(70)90015-2
|
[10]
|
Lowes, D., Al-Shair, K., Newton, P.J., et al. (2017) Predictors of Mortality in Chronic Pulmonary Aspergillosis. European Respiratory Journal, 49, Article ID: 1601062. https://doi.org/10.1183/13993003.01062-2016
|
[11]
|
Ohba, H., Miwa, S., Shirai, M., et al. (2012) Clinical Characteristics and Prognosis of Chronic Pulmonary Aspergillosis. Respiratory Medicine, 106, 724-729. https://doi.org/10.1016/j.rmed.2012.01.014
|
[12]
|
Schweer, K.E., Bangard, C., Hekmat, K., et al. (2014) Chronic Pulmonary Aspergillosis. Mycoses, 57, 257-270.
https://doi.org/10.1111/myc.12152
|
[13]
|
Desai, S.R., Hedayati, V., Patel, K., et al. (2015) Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology. European Radiology, 25, 3100-3107. https://doi.org/10.1007/s00330-015-3690-7
|
[14]
|
Denning, D.W., Page, I.D., Chakaya, J., et al. (2018) Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerging Infectious Diseases, 24, e171312. https://doi.org/10.3201/eid2408.171312
|
[15]
|
Takazono, T. and Izumikawa, K. (2018) Recent Advances in Diagnosing Chronic Pulmonary Aspergillosis. Frontiers in Microbiology, 9, 1810. https://doi.org/10.3389/fmicb.2018.01810
|
[16]
|
Denning, D.W., Cadranel, J., Beigelman-Aubry, C., et al. (2016) Chronic Pulmonary Aspergillosis: Rationale and Clinical Guidelines for Diagnosis and Management. European Respiratory Journal, 47, 45-68.
https://doi.org/10.1183/13993003.00583-2015
|
[17]
|
Maghrabi, F. and Denning, D.W. (2017) The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach. Current Fungal Infection Reports, 11, 242-251.
https://doi.org/10.1007/s12281-017-0304-7
|
[18]
|
Patterson, T.F., Thompson, G.R., Denning, D.W., et al. (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 63, e1-e60.
https://doi.org/10.1093/cid/ciw326
|
[19]
|
Ullmann, A.J., Aguado, J.M., Arikan-Akdagli, S., et al. (2018) Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline. Clinical Microbiology and Infection, 24, e1-e38.
https://doi.org/10.1016/j.cmi.2018.01.002
|
[20]
|
Godet, C., Laurent, F., Bergeron, A., et al. (2016) CT Imaging Assessment of Response to Treatment in Chronic Pulmonary Aspergillosis. Chest, 150, 139-147. https://doi.org/10.1016/j.chest.2016.02.640
|
[21]
|
Meghji, J., Simpson, H., Squire, S.B., et al. (2016) A Systematic Review of the Prevalence and Pattern of Imaging Defined Post-TB Lung Disease. PLoS ONE, 11, e161176. https://doi.org/10.1371/journal.pone.0161176
|
[22]
|
Kim, H.Y., Song, K.S., Goo, J.M., et al. (2001) Thoracic Sequelae and Complications of Tuberculosis. Radiographics, 21, 839-858, 859-860. https://doi.org/10.1148/radiographics.21.4.g01jl06839
|
[23]
|
Smith, M.P. (2017) Diagnosis and Management of Bronchiectasis. CMAJ, 189, E828-E835.
https://doi.org/10.1503/cmaj.160830
|
[24]
|
Dhar, R., Singh, S., Talwar, D., et al. (2019) Bronchiectasis in India: Results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. The Lancet Global Health, 7, e1269-e1279.
|
[25]
|
Kenna, D., Lilley, D., Coward, A., et al. (2017) Prevalence of Burkholderia Species, Including Members of Burkholderia cepacia Complex, among UK Cystic and Non-Cystic Fibrosis Patients. Journal of Medical Microbiology, 66, 490-501. https://doi.org/10.1099/jmm.0.000458
|
[26]
|
Green, H. and Jones, A.M. (2015) The Microbiome and Emerging Pathogens in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis. Seminars in Respiratory and Critical Care Medicine, 36, 225-235.
https://doi.org/10.1055/s-0035-1546752
|
[27]
|
Chandrasekaran, R., Mac, A.M., Chalmers, J.D., et al. (2018) Geographic Variation in the Aetiology, Epidemiology and Microbiology of Bronchiectasis. BMC Pulmonary Medicine, 18, 83. https://doi.org/10.1186/s12890-018-0638-0
|
[28]
|
Altenburg, J., de Graaff, C.S., Stienstra, Y., et al. (2013) Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations among Patients with Non-Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial. JAMA, 309, 1251-1259. https://doi.org/10.1001/jama.2013.1937
|
[29]
|
Serisier, D.J., Martin, M.L., McGuckin, M.A., et al. (2013) Effect of Long-Term, Low-Dose Erythromycin on Pulmonary Exacerbations among Patients with Non-Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial. JAMA, 309, 1260-1267. https://doi.org/10.1001/jama.2013.2290
|
[30]
|
Shah, N.M., Davidson, J.A., Anderson, L.F., et al. (2016) Pulmonary Mycobacterium avium-intracellulare Is the Main Driver of the Rise in Non-Tuberculous Mycobacteria Incidence in England, Wales and Northern Ireland, 2007-2012. BMC Infectious Diseases, 16, 195. https://doi.org/10.1186/s12879-016-1521-3
|
[31]
|
Fowler, S.J., French, J., Screaton, N.J., et al. (2006) Nontuberculous Mycobacteria in Bronchiectasis: Prevalence and Patient Characteristics. European Respiratory Journal, 28, 1204. https://doi.org/10.1183/09031936.06.00149805
|
[32]
|
Hsing, S.C., Weng, S.F., Cheng, K.C., et al. (2013) Increased Risk of Pulmonary Tuberculosis in Patients with Previous Non-Tuberculous Mycobacterial Disease. International Journal of Tuberculosis and Lung Disease, 17, 928-933.
https://doi.org/10.5588/ijtld.12.0675
|
[33]
|
Swensen, S.J., Hartman, T.E. and Williams, D.E. (1994) Computed Tomographic Diagnosis of Mycobacterium avium-intracellulare Complex in Patients with Bronchiectasis. Chest, 105, 49-52.
https://doi.org/10.1378/chest.105.1.49
|
[34]
|
Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., et al. (2007) An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Journal of Respiratory and Critical Care Medicine, 175, 367-416. https://doi.org/10.1164/rccm.200604-571ST
|
[35]
|
Haworth, C.S., Banks, J., Capstick, T., et al. (2017) British Thoracic Society Guidelines for the Management of Non-Tuberculous Mycobacterial Pulmonary Disease (NTM-PD). Thorax, 72, i1-i64.
https://doi.org/10.1136/thoraxjnl-2017-210927
|
[36]
|
Oei, W. and Nishiura, H. (2012) The Relationship between Tuberculosis and Influenza Death during the Influenza (H1N1) Pandemic from 1918-19. Computational and Mathematical Methods in Medicine, 2012, Article ID: 124861.
https://doi.org/10.1155/2012/124861
|
[37]
|
Zürcher, K., Zwahlen, M., Ballif, M., et al. (2016) Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland. PLoS ONE, 11, e162575. https://doi.org/10.1371/journal.pone.0162575
|
[38]
|
Small, C.L., Shaler, C.R., McCormick, S., et al. (2010) Influenza Infection Leads to Increased Susceptibility to Subsequent Bacterial Superinfection by Impairing NK Cell Responses in the Lung. The Journal of Immunology, 184, 2048-2056. https://doi.org/10.4049/jimmunol.0902772
|
[39]
|
Muñoz-Torrico, M., Rendon, A., Centis, R., et al. (2016) Is There a Rationale for Pulmonary Rehabilitation Following Successful Chemotherapy for Tuberculosis? Jornal Brasileiro de Pneumologia, 42, 374-385.
https://doi.org/10.1590/S1806-37562016000000226
|
[40]
|
Zhang, C., Wang, Y., Shi, G., et al. (2016) Determinants of Multidrug-Resistant Tuberculosis in Henan Province in China: A Case Control Study. BMC Public Health, 16, 42. https://doi.org/10.1186/s12889-016-2711-z
|
[41]
|
Chalmers, J.D., Aliberti, S. and Blasi, F. (2015) Management of Bronchiectasis in Adults. European Respiratory Journal, 45, 1446-1462. https://doi.org/10.1186/s12889-016-2711-z
|